Olszewska-Pazdrak B, Hein TW, Olszewska P, Carney DH. Chronic hypoxia attenuates VEGF signaling and angiogenic responses by downregulation of KDR in human endothelial cells. Am J Physiol Cell Physiol 296: C1162-C1170, 2009. First published February 25, 2009 doi:10.1152/ajpcell.00533.2008.-Coronary artery disease results in progressive vascular stenosis associated with chronic myocardial ischemia. Vascular endothelial growth factor (VEGF) stimulates endothelial cell angiogenic responses to revascularize ischemic tissues; however, the effect of chronic hypoxia on the responsiveness of endothelial cells to VEGF remains unclear. We, therefore, investigated whether hypoxia alters VEGF-stimulated signaling and angiogenic responses in primary human coronary artery endothelial (HCAE) cells. Exposure of HCAE cells to hypoxia (1% O2) for 24 h decreased VEGF-stimulated endothelial cell migration (ϳ82%), proliferation (ϳ30%), and tube formation. Hypoxia attenuated VEGFstimulated activation of endothelial nitric oxide (NO) synthase (eNOS) (ϳ72%) and reduced NO production in VEGF-stimulated cells from 237 Ϯ 38.8 to 61.3 Ϯ 28.4 nmol/l. Moreover, hypoxia also decreased the ratio of phosphorylated eNOS to total eNOS in VEGFstimulated cells by ϳ50%. This effect was not observed in thrombinstimulated cells, suggesting that hypoxia specifically inhibited VEGF signaling upstream of eNOS phosphorylation. VEGF-induced activation of Akt, ERK1/2, p38, p70S6 kinases, and S6 ribosomal protein was also attenuated in hypoxic cells. Moreover, VEGF-stimulated phosphorylation of VEGF receptor-2 (KDR) at Y996 and Y1175 was decreased by hypoxia. This decrease correlated with a 70 Ϯ 12% decrease in KDR protein expression. Analysis of mRNA from these cells showed that hypoxia reduced steady-state levels of KDR mRNA by 52 Ϯ 16% and decreased mRNA stability relative to normoxic cells. Our findings demonstrate that chronic hypoxia attenuates VEGF-stimulated signaling in HCAE cells by specific downregulation of KDR expression. These data provide a novel explanation for the impaired angiogenic responses to VEGF in endothelial cells exposed to chronic hypoxia.
-Coronary artery disease results in progressive vascular stenosis associated with chronic myocardial ischemia. Vascular endothelial growth factor (VEGF) stimulates endothelial cell angiogenic responses to revascularize ischemic tissues; however, the effect of chronic hypoxia on the responsiveness of endothelial cells to VEGF remains unclear. We, therefore, investigated whether hypoxia alters VEGF-stimulated signaling and angiogenic responses in primary human coronary artery endothelial (HCAE) cells. Exposure of HCAE cells to hypoxia (1% O2) for 24 h decreased VEGF-stimulated endothelial cell migration (ϳ82%), proliferation (ϳ30%), and tube formation. Hypoxia attenuated VEGFstimulated activation of endothelial nitric oxide (NO) synthase (eNOS) (ϳ72%) and reduced NO production in VEGF-stimulated cells from 237 Ϯ 38.8 to 61.3 Ϯ 28.4 nmol/l. Moreover, hypoxia also decreased the ratio of phosphorylated eNOS to total eNOS in VEGFstimulated cells by ϳ50%. This effect was not observed in thrombinstimulated cells, suggesting that hypoxia specifically inhibited VEGF signaling upstream of eNOS phosphorylation. VEGF-induced activation of Akt, ERK1/2, p38, p70S6 kinases, and S6 ribosomal protein was also attenuated in hypoxic cells. Moreover, VEGF-stimulated phosphorylation of VEGF receptor-2 (KDR) at Y996 and Y1175 was decreased by hypoxia. This decrease correlated with a 70 Ϯ 12% decrease in KDR protein expression. Analysis of mRNA from these cells showed that hypoxia reduced steady-state levels of KDR mRNA by 52 Ϯ 16% and decreased mRNA stability relative to normoxic cells. Our findings demonstrate that chronic hypoxia attenuates VEGF-stimulated signaling in HCAE cells by specific downregulation of KDR expression. These data provide a novel explanation for the impaired angiogenic responses to VEGF in endothelial cells exposed to chronic hypoxia. ischemia; endothelial dysfunction; angiogenesis; endothelial nitric oxide synthase CORONARY ARTERY DISEASE is characterized by atherosclerotic stenosis of vessels responsible for perfusion of the heart resulting in chronic myocardial ischemia (41) . Hypoxia is a strong stimulus to induce angiogenesis and the development of collateral vessels that restore perfusion to ischemic myocardial tissue following vascular occlusion. The prevalence of coronary artery disease, however, demonstrates that normal angiogenic responses to hypoxia are often not sufficient to maintain healthy tissues in many patients.
Hypoxia plays a critical role in angiogenesis by regulating the transcription of multiple growth factors, which are produced by hypoxic parenchymal cells in tissues and activate an angiogenic program in endothelial cells, leading to increased tissue perfusion (6, 39) . Hypoxia also directly modulates expression of a number of genes in endothelial cells (31) . Hypoxia is a strong inducer of vascular endothelial growth factor (VEGF) expression in animal models of myocardial ischemia (2) and in numerous cell types, including cardiac myocytes (25) , vascular smooth muscle cells (5), monocytes (19) , and endothelial cells (29, 51) .
VEGF is a critical regulator of vascular development during embryogenesis and for new blood vessel formation to restore circulation following vascular occlusion in adults (6) . VEGFinduced activation of specific receptors is critically involved in differentiation of endothelial cell progenitors, endothelial cell sprouting, increased endothelial cell permeability, migration, proliferation, and cell survival (6) . Two tyrosine kinase receptors that specifically bind VEGF have been identified on endothelial cells, VEGF receptor-1 (VEGFR-1, Flt-1), and VEGFR-2 (KDR) (48) . The multiple signaling pathways activated on VEGF stimulation include Akt, PLC-␥, Src, ERK, p38, JNK, and focal adhesion kinase (FAK) (7) . VEGF also activates endothelial nitric oxide (NO) synthase (eNOS) to stimulate NO production (35) . It has been shown that VEGFinduced NO production is required for VEGF-stimulated endothelial cell proliferation (36) , migration (9, 34) , tube formation (28) , and angiogenesis (14, 33, 52) .
In experimental animals, revascularization and recovery of blood flow to ischemic tissue is increased by administration of angiogenic cytokines such as VEGF (40, 44) , but human clinical trials with VEGF and other angiogenic agents such as fibroblast growth factor (FGF) have been less successful than anticipated (3, 27, 30) . The differences between the dramatic responses in animals and disappointing clinical outcomes may involve different responsiveness of endothelial cells in young healthy animals used in laboratory studies compared with the endothelial cell responses in clinical trial patients with chronic myocardial ischemia.
The effect of chronic hypoxia on VEGF-mediated signaling and angiogenic responses in human endothelial cells has not been elucidated. We hypothesized that exposure of endothelial cells to chronic hypoxia alters responsiveness of these cells to VEGF. Thus the purpose of this study was to determine whether chronic hypoxia affects VEGF-stimulated intracellular signaling, NO production, and angiogenic responses in primary human coronary artery endothelial (HCAE) cells.
Our results show that exposure of HCAE cells to chronic hypoxia attenuates VEGF-stimulated activation of multiple signaling pathways, endothelial cell functions, and phosphorylation of KDR. These effects of chronic hypoxia correlate with the specific downregulation of KDR expression. These results provide a novel explanation for impaired endothelial cell responsiveness to VEGF during chronic hypoxia. Our demonstration that chronic hypoxia attenuates responses of endothelial cells to an angiogenic factor such as VEGF is very important because of the central role played by VEGF in angiogenesis and its potential as a therapeutic for ischemic cardiovascular disease.
MATERIALS AND METHODS
Endothelial cell culture. Human coronary artery endothelial (HCAE) cells isolated from three different donors (age 25, 31, and 36 years) were purchased from Cambrex BioScience (Walkersville, MD). Cells were used between passages 4 and 7 for experiments to avoid effects of in vitro cell aging (50) . Cells were cultured in endothelial cell basal medium (EBM) with 5% fetal bovine serum (FBS) and growth factors (SingleQuots, Clonetics, San Diego, CA) in 5% CO 2 at 37°C. Two-day postconfluent cultures of HCAE cells were then exposed to normoxic or hypoxic (1% O 2, 5% CO2 at 37°C) conditions for 24 h. Hypoxia was maintained during cell treatment using a specially designed hypoxic glove box (Coy Laboratory Products). Normoxic and hypoxic HCAE cells were treated with VEGF (recombinant human VEGF-A 165, R&D system, Minneapolis, MN) at 50 ng/ml unless otherwise indicated or with control vehicle alone and analyzed as described below.
Western blot analysis. After treatment, cells were solubilized in lysis buffer (150 mM NaCl, 50 mM HEPES, pH 7.4, 1 mM EGTA, 1 mM Na 3VO4, 10 mM NaF, 1 mM phenylmethylsulfonyl fluoride, 5% glycerol, 1% Triton X-100) containing a protease inhibitor mixture (Complete, Roche Diagnostics). Cell lysates were subjected to SDS-PAGE and transferred to nitrocellulose membranes (0.2 m, Invitrogen). Membranes were incubated overnight at 4°C with primary antibodies against phospho-eNOS (S1177), eNOS, phospho-Akt (S473), Akt, phospho-ERK1/2 (T202/Y204), phospho-p38 (T180/ Y182), p38, phospho-p70S6 kinase (T421/S424), phospho-S6 Ribosomal Protein (S240/244), S6 Ribosomal Protein, phospho-KDR (Y996), phospho-KDR (Y1175) (Cell Signaling Technology, Beverly, MA), KDR, ERK1/2, or GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA). Immunoblots were developed using Immobilon Western Detection Reagents (Millipore, Billerica, MA). Densitometric analysis was performed using Quantity One software (Bio-Rad Laboratories, Hercules, CA). Densitometric data were normalized to the normoxic control values in each experiment (expressed as 1.0).
Real-time PCR. Quantitative SYBR green real-time PCR was used to determine expression of eNOS and KDR mRNA. Total RNA was isolated using RNAqueous kits (Ambion, Austin, TX). Isolated mRNA samples were coded for blinded analysis. Total RNA was reverse transcribed using Taqman Reverse Transcription Reagents Kits (ABI). Quantitative PCR amplifications were done using 2 l of cDNA in total volume of 25 l using SYBR Green PCR Master Mix (ABI) on an ABI Prism 7000 Sequence Detection System. Primers for human eNOS were sense: GCG GCT GCA TGA CAT TGA G; antisense: GTC GCG GTA GAG ATG GTC AAG T. Primers for human KDR were sense: TGC CTC AGA AGA GCT GAA AAC TT; anti-sense: CAC AGA CTC CCT GCT TTT GCT. Reverse-transcribed cDNA cycle threshold values were calculated from triplicate sample determinations and normalized to 18S RNA.
mRNA stability analysis. To determine KDR mRNA stability, actinomycin D (5 g/ml) (Biomol, Plymouth Meeting, PA) was added to HCAE cells 24 h after exposure to normoxia or hypoxia. Cells were incubated for an additional 1-6 h in normoxic or hypoxic conditions. Total RNA was isolated and analyzed by quantitative SYBR Green real-time PCR as described above.
NO assay. Two-day postconfluent HCAE cells were cultured in normoxic or hypoxic conditions for 24 h. The medium was replaced with EBM containing 200 M L-arginine, and cells were stimulated with VEGF in the same conditions. After 1 h, culture medium was collected, coded, and analyzed in blinded fashion using a chemiluminescence NO analyzer (model 270B, Sievers Instruments, Boulder, CO) as previously described (21) .
Migration assay. Transmembrane cell migration assays were performed using BD FluoroBlok inserts (BD Biosciences, Bedford, MA). HCAE cells (5 ϫ 10 4 cells) suspended in 250 l of EBM containing 0.1% FBS were added into the top of the inserts. The lower chamber was filled with 750 l of medium alone or medium containing VEGF. After 24 h of normoxic or hypoxic incubation, cells were labeled with calcein AM (4 g/ml). Migration was determined by quantifying the fluorescence of cells that migrated to the underside of the insert membranes. Preliminary studies showed maximal migration of normoxic cells to 10 ng/ml VEGF. Therefore, this concentration was used for transmembane migration studies.
Proliferation assay. HCAE cells plated on 96-well plates were treated with VEGF. DNA synthesis was determined by bromodeoxyuridine (BrdU) incorporation (Cell Proliferation ELISA, Roche Diagnostics, Indianapolis, IN) during 24 h normoxic or hypoxic incubation.
Tube formation assay. HCAE cells (2 ϫ 10 4 cells/well of 48-well plate) were plated on growth factor-reduced Matrigel Matrix (BD Biosciences, Bedford, MA) in the absence or presence of VEGF. Endothelial cell tube formation was photographed after 24 h normoxic or hypoxic incubation.
Statistical analysis. Data are presented as means Ϯ SD. Statistical difference was evaluated by Student's t-test. P value of Ͻ0.05 was regarded as significant.
RESULTS

Hypoxia decreases VEGF-stimulated endothelial cell migration, proliferation, and capillary tube formation.
To evaluate the effect of chronic hypoxia on VEGF-stimulated angiogenic responses in vitro, we compared endothelial cell migration, proliferation, and tube formation in normoxic and hypoxic conditions. VEGF increased endothelial cell migration by approximately twofold when assays were performed under normoxic conditions (Fig. 1A) . However, when endothelial cells were exposed to hypoxia for 24 h, both basal and VEGFstimulated endothelial migration were decreased by 35% and 82%, respectively, compared with normoxic cells (Fig. 1A) . Furthermore, VEGF treatment of normoxic cells resulted in a 1.8-fold increase DNA synthesis as assessed by BrdU incorporation (Fig. 1B) . However, chronic hypoxia reduced VEGFstimulated BrdU incorporation by ϳ38% compared with normoxic cells. Notably, hypoxia did not affect cell viability in these experiments (data not shown). Exposure of HCAE cells to hypoxia also resulted in attenuation of basal and VEGFstimulated endothelial tube formation compared with normoxic cells (Fig. 1C) . Thus chronic hypoxia reduced endothelial cell migration, DNA synthesis, and tube formation in response to VEGF treatment.
Hypoxia decreases VEGF-stimulated NO production. VEGF stimulates rapid NO production by endothelial cells (20, 35) . VEGF-induced NO production has been shown to be required for VEGF-mediated endothelial cell proliferation (35, 36) , migration (9), tube formation (28) , and angiogenesis in vivo (52) . To determine the effect of chronic hypoxia on VEGFstimulated NO production, HCAE cells were cultured in normoxic and hypoxic conditions for 24 h, and NO produced by the cells during 1 h stimulation was assessed as described in MATERIALS AND METHODS. As shown in Fig. 2A , stimulation of normoxic HCAE cells with VEGF resulted in a 2.3-fold increase in NO production compared with control cells (237 Ϯ 38 vs. 102 Ϯ 17 nM). The basal level of NO production was decreased in hypoxic cells by ϳ50% (102 Ϯ 17 vs. 48 Ϯ 13 nM). Treatment of hypoxic cells with VEGF did not significantly increase NO production ( Fig. 2A) . Thus hypoxia significantly reduced both basal and VEGF-stimulated levels of NO production in HCAE cells.
Hypoxia decreases VEGF-stimulated eNOS activation. Results of cell function assays and NO production by HCAE cells showed that hypoxia reduced both basal levels of response and the levels of response stimulated by VEGF. To determine whether hypoxic effects on VEGF stimulation was specific, we examined the VEGF signaling pathways involved in activation of eNOS and other cellular functions. VEGF stimulates NO production in endothelial cells by phosphorylation of eNOS at S1177 (15) . VEGF treatment induced rapid and transient phosphorylation of eNOS at S1177 in normoxic HCAE cells (Fig.  2B) . eNOS phosphorylation was maximal at 1 min after VEGF stimulation (3.4 Ϯ 1.6-fold) and declined to basal level by 30 min. VEGF-induced eNOS phosphorylation was significantly reduced at all time points in hypoxic cells (Fig. 2B) . In hypoxic cells the maximal level of VEGF-stimulated eNOS phosphorylation was similar to the basal level in nonstimulated normoxic cells (0.9 Ϯ 0.5 vs. 1.0). Thus chronic hypoxia significantly impaired eNOS activation by VEGF.
In these HCAE cells, hypoxia decreased eNOS protein expression by 45 Ϯ 12% (Fig. 3, A and B) . Similarly, real-time PCR analyses showed that the steady-state levels of eNOS mRNA was reduced by 67 Ϯ 10% in cells exposed to hypoxia for 24 h (Fig. 3C) . The reduction in eNOS protein, however, did not fully explain the hypoxia-induced decrease in VEGFstimulated eNOS phosphorylation (Fig. 3D ). As shown in Fig.  3E , the ratio of phosphorylated eNOS to total eNOS following VEGF treatment was decreased by ϳ50% by hypoxia (3.2 vs. 6.6-fold increase over control). Interestingly, treatment of HCAE cells with thrombin, which activates eNOS by stimulation of the PAR1 receptor (32), resulted in phospho-eNOS-to eNOS ratios that were similar in normoxic and hypoxic cells (7.8 vs. 8.0-fold increase over control). These unexpected results suggested that hypoxia selectively affects signaling events upstream of eNOS phosphorylation that are stimulated by VEGF but not by thrombin.
Hypoxia attenuates VEGF-stimulated phosphorylation of Akt, ERK1/2, p38, p70S6 kinase (p70S6K), and S6 ribosomal protein (S6RP). Our results suggested that hypoxia selectively inhibits VEGF-induced eNOS phosphorylation. It was therefore important to determine whether other signaling pathways stimulated by VEGF were also altered in hypoxic cells. A number of kinases are activated in response to VEGF stimulation. Akt stimulation plays a role in eNOS activation, cell survival in response to VEGF and in vivo angiogenesis (1, 15, 17, 28) . Activation of ERK1/2 and p38 kinases is required for VEGF-stimulated endothelial cell proliferation and migration (22, 36) . In addition, activation of p70S6K and S6RP stimulate protein synthesis (37) and promote cell growth and proliferation.
In normoxic HCAE cells, VEGF increased phosphorylation of Akt at 10 to 30 min, but in hypoxic cells the level of Akt phosphorylation was attenuated at 10 min and returned to basal level by 30 min (Fig. 4) . VEGF-stimulated phosphophorylation of ERK1/2 peaked in normoxic cells at 5 min and then gradually decreased but still remained threefold elevated at 30 min compared with normoxic control cells (Fig. 4) . In hypoxic cells, VEGF-stimulated phosphorylation was diminished relative to normoxic cells, peaked at 5 min, but decreased to basal level by 30 min (Fig. 4) . VEGF also induced transient phosphorylation of p38 kinase in normoxic cells from 5 to 10 min. In hypoxic cells, however, VEGF-induced phosphorylation of p38 was barely detectable at 5 min (Fig. 4) . VEGF also stimulated phosphorylation of p70S6K in normoxic cells maximally from 5 to 30 min. Hypoxia attenuated the magnitude and duration of p70S6K phosphorylation, which returned close to basal level by 30 min (Fig. 4) . The basal level of S6RP phosphorylation was relatively high in normoxic cells and was increased in response to VEGF at 30 min (Fig. 4) . Chronic hypoxia decreased the basal level of S6RP phosphorylation by 78 Ϯ 12% compared with normoxic cells. VEGF-stimulated phosphorylation of S6RP in hypoxic cells was detectable at 10 and 30 min, but the magnitude of the phosphorylation was below the basal levels observed in normoxic control cells (Fig.  4) . Hypoxia had no significant effect on the levels of Akt, ERK1/2, p38, and S6RP protein expression. Thus the decreased levels of VEGF-stimulated activation of these kinases were not due to downregulation of protein expression. These results therefore show that in addition to its effects on eNOS activation, hypoxia decreased in a coordinated fashion the duration and magnitude of VEGF-stimulated activation of Akt, ERK1/2, p38, p70S6K, and S6RP. (12, 18) . Our results showed that hypoxia decreased both VEGF-stimulated endothelial cell migration and proliferation and signaling pathways regulated by KDR. We therefore examined whether KDR receptor activation and/or expression was affected in hypoxic cells. We observed VEGF-induced phosphorylation of KDR at Y996 and Y1175 in normoxic cells as early as 1 min, reaching maximal phosphorylation at 5 min (Fig. 5A) . In comparison, the maximal levels of VEGF-stimulated KDR phosphorylation at Y996 and Y1175 were decreased in hypoxic cells by ϳ2.6-fold and ϳ4.5-fold, respectively (Fig. 5B) .
Hypoxia attenuates VEGF-stimulated phosphorylation of KDR and downregulates KDR expression. VEGF induces proliferation and endothelial cell migration by activation of VEGF receptor-2 (KDR)
Decreased KDR activation could explain the coordinated effect of hypoxia that resulted in decreased magnitude and duration of VEGF-induced activation of several signaling pathways. This decrease in KDR activation could be caused by hypoxia-activated inhibitory factors that might prevent VEGF from phosphorylation of the receptor or specific changes in the receptor itself. We therefore determined whether this effect was due to altered KDR expression in hypoxic cells.
Western blot analysis of HCAE cells using anti-KDR antibody detected three KDR bands corresponding to the immature form (ϳ160 kDa), intermediate glycosylated form (ϳ230 kDa), and mature glycosylated form (ϳ260 kDa) (Fig. 6A) . Hypoxia decreased all forms of KDR protein expression with the glycosylated forms reduced by 70 Ϯ 12% (Fig. 6, A and B) . Consistent with previous reports (11, 43) , following VEGF treatment, the ϳ260-kDa gylcosylated form of KDR was degraded in nomoxic and hypoxic cells (Fig. 6A ). This form of KDR also corresponds in size to the KDR form phosphorylated after VEGF stimulation (Fig. 5A) . We also determined whether hypoxia affected the expression of VEGFR-1 (Flt-1). In contrast to the hypoxia-induced decrease in KDR expression, hypoxia had no effect or slightly increased Flt-1 expression relative to normoxic cells (Fig. 6A) . Thus hypoxia specifically downregulated expression of KDR in these cells.
Analysis of the ratio of phospho-KDR to total KDR protein expression can help establish whether hypoxia affects VEGF signaling through decreased expression alone or if other inhibitory factors are involved. The ratios of KDR phosphorylation at Y996 after 5 min of VEGF stimulation to total KDR expression after 24 h of normoxic and hypoxic exposure were 12.76 Ϯ 2.19 (n ϭ 3) and 12.53 Ϯ 2.14 (n ϭ 3), respectively. Additionally, the ratios of KDR phosphorylation after 5 min at Y1175 to total KDR expression for normoxic and hypoxic cells were 11.96 Ϯ 1.66 (n ϭ 3) and 10.85 Ϯ 1.98 (n ϭ 3), respectively. That the ratios were similar in normoxic and hypoxic cells suggests that hypoxia-induced attenuation of VEGF-stimulated KDR phosphorylation was primarily due to decreased KDR expression in hypoxic cells.
Mechanistically, it was important to determine whether hypoxia-induced KDR downregulation was due to changes in the level of mRNA expression. Exposure of HCAE cells to hypoxia reduced the steady-state levels of KDR mRNA by 52 Ϯ 16% after 24 h (Fig. 6C) . In addition, mRNA stability studies showed that hypoxia significantly decreased KDR mRNA stability (Fig. 6D) . The apparent half-life of KDR mRNA was ϳ6 h in normoxic cells but only ϳ3.5 h in hypoxic cells (Fig. 6D) . In contrast, hypoxia did not decrease Flt-1 Fig. 2 . Hypoxia decreases VEGF-stimulated nitric oxide (NO) production and endothelial NO synthase (eNOS) phosphorylation. HCAE cells were cultured in normoxic or hypoxic (1% O2) conditions for 24 h. A: NO production stimulated by VEGF (50 ng/ml) during 1 h continued normoxic or hypoxic incubation. *P Ͻ 0.05 compared with normoxic control (CTR), n ϭ 3. B: eNOS activation stimulated by VEGF (50 ng/ml) for the indicated times was determined by Western blotting using antibody specific for eNOS phosphorylated at S1177. GAPDH blot serves as a protein loading control. Bar graph represents quantitative densitometric analyses of activated eNOS after VEGF treatment in normoxic and hypoxic conditions. *P Ͻ 0.05 compared with the same time point in normoxic cells, n ϭ 4. mRNA stability (data not shown). These results demonstrate that hypoxia selectively downregulated KDR expression in HCAE cells, at least in part, by decreasing KDR mRNA stability.
DISCUSSION
The present studies were undertaken to define the effects of chronic hypoxia on VEGF signaling and VEGF-stimulated angiogenic responses in human primary coronary artery endothelial cells. We have demonstrated for the first time that exposure of HCAE cells to chronic hypoxia impaired VEGFstimulated cell functions, including endothelial cell migration, proliferation, and tube formation. Moreover, our data showed that VEGF-stimulated activation of intracellular signaling was significantly attenuated in hypoxic cells by specific downregulation of KDR expression.
Hypoxia-induced upregulation of VEGF plays a key role in stimulating angiogenesis and collateral vessel formation (6, 7) . However, normal angiogenic responses to hypoxia, including the ability of VEGF to induce angiogenesis, are often defective in patients with vascular disease as suggested by the prevalence of myocardial ischemia and peripheral artery disease (23) . It was therefore thought that exogenously added VEGF or VEGF gene therapy would restore vascularization in ischemic tissues (23) . Although therapeutic angiogenesis with VEGF showed convincing results in animal models, clinical trials using VEGF or VEGF gene therapy were less successful than anticipated (3, 27, 30) . This suggested that endothelial cell responsiveness to VEGF might be impaired in patients with chronically ischemic tissues. Thus, to develop more effective therapeutics for treatment of myocardial ischemia, we need to better understand how hypoxia affects endothelial cell function.
To study potential mechanisms by which hypoxia might impair responses to VEGF in patients with coronary artery disease, we cultured primary HCAE cells and then exposed them to normoxic or hypoxic (1% O 2 ) conditions for 24 h. Because age has been reported to decrease VEGF receptor expression and vasodilation in rat coronary arterioles (26), we selected HCAE cells from young donors between the ages 25 and 36 years.
Our results showed that hypoxia attenuated VEGF-stimulated endothelial cell functions. In addition, we observed that hypoxia also affected the basal level of endothelial cell migration, tube formation, and NO production. Thus it was important to determine whether hypoxia had direct specific effects on VEGF signaling involved in these cellular functions. We therefore compared VEGF-stimulated signaling in normoxic and hypoxic cells.
Recent studies have shown that NO production by eNOS is required for VEGF-induced endothelial cell proliferation (36), Fig. 3 . Hypoxia downregulates eNOS expression and specifically decreases VEGF-stimulated ratio of phospho-eNOS to eNOS. HCAE cells were cultured in normoxic or hypoxic (1% O2) conditions for 24 h. A: eNOS protein expression was determined by Western blotting. The membrane was reprobed with GAPDH antibody to show equal protein loading. B: bar graph shows densitometric analyses of eNOS protein expression in normoxic (norm) and hypoxic (1% hyp) cells. *P Ͻ 0.01 compared with normoxic cells, n ϭ 4. C: real-time PCR analyses of eNOS mRNA expression in normoxic (norm) and hypoxic (1%hyp) cells. *P Ͻ 0.01 compared with normoxic cells, n ϭ 5. D: cells were stimulated with VEGF (50 ng/ml) or thrombin (2 U/ml) for 1 or 5 min in normoxic or hypoxic conditions. eNOS activation was determined by Western blotting using phospho-eNOS (S1177) antibody and reprobed with antibody recognizing total eNOS. E: bar graph of the ratio of phospho-eNOS to eNOS from blot shown in D. Data are representative of results from three experiments. migration (9, 34) , tube formation (28) , and angiogenesis (14, 33, 52) . Our study showed that in hypoxic cells, VEGFstimulated cellular functions related to angiogenesis are significantly attenuated and that hypoxia decreases eNOS expression, activation, and NO production. Hypoxia-induced eNOS downregulation alone could explain the decrease in VEGFstimulated NO production and NO-dependent cell functions. However, we found that the ratio of eNOS phosphorylation at S1177 to total eNOS protein following VEGF treatment was decreased in hypoxic cells suggesting that hypoxia also affected upstream VEGF signaling.
Previous studies have shown decreased expression of eNOS during prolonged exposure of endothelial cells or myocardial tissues to hypoxia (13, 38, 46) . Moreover, we recently showed that endothelial cell exposure to hypoxia decreased basal levels of eNOS activation (13) . Our current finding that hypoxia decreased VEGF-induced eNOS activation, however, suggested a specific effect on VEGF signaling. To determine whether the effect of hypoxia was specific for VEGF signaling, we compared the phosphorylation of eNOS stimulated by VEGF and thrombin, which acts through G-protein coupled PAR receptors (32) . In contrast to what we observed with VEGF stimulation, the ratio of phospho-eNOS to total eNOS were similar in normoxic and hypoxic cells after thrombin stimulation. These data suggested that in addition to any hypoxic effects on basal levels of eNOS expression or activation, hypoxia also specifically attenuated VEGF-regulated signaling pathways upstream of eNOS phosphorylation.
The specific effects of hypoxia on VEGF-stimulated eNOS phosphorylation raised the question of whether hypoxia might also inhibit other VEGF signaling pathways related to angiogenesis. Our data demonstrate that exposure of HCAE cells to hypoxia decreased the magnitude and duration of VEGFstimulated activation of several kinases involved in angiogenic responses. These included Akt, that is involved in eNOS activation, endothelial cell survival and angiogenesis in vivo (1, 15, 17, 28) , ERK1/2 and p38 kinases that are necessary for VEGF-induced endothelial cell proliferation and migration (22, 36) , and p70S6K and S6RP required for stimulation of protein synthesis and cell growth (37) .
Our results, demonstrating that hypoxia attenuated VEGFstimulated cell functions and VEGF activation of multiple Fig. 5 . Hypoxia decreases VEGF-stimulated KDR phosphorylation. HCAE cells were cultured in normoxic or hypoxic (1% O2) conditions for 24 h and stimulated in the same conditions with VEGF (50 ng/ml) for the indicated times. A: KDR phosphorylation was determined by Western blotting using antibody specific for KDR phosphorylated at Y996 and Y1175. The membrane was reprobed with GAPDH antibody to show equal protein loading. B: bar graphs show densitometric analyses of VEGF-stimulated KDR phosphorylation at Y996 and Y1175 in normoxic (normoxia) and hypoxic (1% hypoxia) cells. *P Ͻ 0.01 compared with normoxic cells, n ϭ 4. Fig. 4 . Hypoxia abrogates VEGF-stimulated activation of Akt, ERK, p38, p70S6 kinase (p70S6K), and S6 ribosomal protein (S6RP). HCAE cells were cultured in normoxic or hypoxic (1% O2) conditions for 24 h and stimulated in the same conditions with VEGF (50 ng/ml) for the indicated times. Kinase activation was determined by Western blotting using antibodies specific for phosphorylated Akt (S473), ERK1/2 (T202/T204), p38 kinase (T180/Y182), p70S6K (T421/S424), and S6RP (S240/244) and reprobed with antibody recognizing total Akt, ERK1/2, p38, and S6RP. GAPDH blot serves as a protein loading control.
kinases, raised the possibility that hypoxia may affect activation or expression of VEGF receptors. Previous studies have shown that VEGF-dependent endothelial cell tube formation, proliferation, and migration are mediated by activation of KDR (12, 18) . In addition, KDR silencing by its cognate siRNA or KDR inhibition by ZM-323881 significantly attenuated VEGFmediated signaling including phosphorylation of ERK, p38, Akt, and eNOS (12, 24) . We therefore examined the effects of hypoxia on KDR activation and expression. We found that VEGF-stimulated phosphorylation of KDR at Y996, located in the kinase insert domain (10) and phosphorylation at Y1175, involved in activation of pathways via PLC␥-1 and endothelial cell proliferation (45), were both decreased in hypoxic cells. Decreased activation of KDR alone could explain the hypoxiainduced attenuation of multiple signaling pathways. We found, however, that hypoxia also reduced the expressed levels of KDR protein. In contrast, hypoxia did not reduce expression of VEGF receptor 1 (Flt-1) protein. These data demonstrate specific effects of hypoxia on downregulation of KDR receptor. In addition, the ratio of phospho-KDR to total KDR expression were similar in hypoxic and normoxic cells, suggesting that hypoxia-mediated attenuation of VEGF-stimulated KDR phosphorylation and subsequent signaling was due to the decrease in KDR protein expression in hypoxic cells.
Of several possible mechanisms involved in downregulation of KDR protein expression by hypoxia, we found that decreased expression of KDR results from decreased steady-state levels of KDR mRNA. Our data show that this decrease is, at least in part, due to decreased mRNA stability. Previous studies indicated that hypoxia had no affect on KDR promoter activity in HUVEC (16) . This study together with our results suggest that the hypoxia-induced decrease in KDR mRNA observed in our studies involves message instability and not decreased transcription.
The effects of hypoxia on KDR and Flt-1 expression in HCAE cells appear to be quite different. Whereas hypoxia consistently downregulated KDR expression, we found that hypoxia did not decrease Flt-1 protein expression and in some experiments increased Flt-1 mRNA levels by up to 2.4-fold over normoxic cells (data not shown). These results are consistent with previous studies showing that hypoxia induced transcription of Flt-1 (16) . VEGF-induced activation of Flt-1 was recently shown to activate Akt and eNOS resulting in increased vascular permeability (47) . Our studies showing that hypoxia-induced downregulation of KDR attenuates activation of Akt, eNOS, and several other kinases while not downregulating Flt-1; however, support prior studies indicating VEGF activation of KDR is responsible for most of the VEGF-related angiogenic effects (12, 24, 42) .
Our findings of downregulation of KDR protein expression by hypoxia is novel since previous studies reported upregulation of KDR protein in HUVEC exposed to 2% O 2 for 24 h (49), and no effect of hypoxia on 125 I-labeled VEGF binding to KDR in microvascular endothelial cells (4) . Consistent with our results, however, it was reported that hypoxia decreased KDR mRNA in dermal microvascular endothelial cells (8) . The mechanisms for different outcomes in these studies are not known and may involve selective responses to hypoxia by endothelial cells isolated from different tissues or experimental differences in hypoxic conditions.
The specific downregulation of KDR by chronic hypoxia may represent a novel physiological regulatory mechanism to direct angiogenesis. Downregulation of KDR by chronic hypoxia, for example, may ensure that the VEGF released from hypoxic cells selectively targets nonischemic endothelial cells that are outside of the ischemic region for angiogenic responses. In myocardial ischemia and peripheral vascular disease, however, this effect of chronic hypoxia extended over a large area may contribute to the impairment of tissue revascularization.
In summary, we demonstrate that chronic hypoxia attenuates VEGF-stimulated signaling and angiogenic responses in human coronary artery endothelial cells. Our results show that specific downregulation of KDR receptor expression in hypoxic cells attenuated VEGF-stimulated KDR phosphorylation and the subsequent activation of Akt, ERK1/2, p38, p70S6K, S6RP, eNOS, and NO production. Thus our finding of specific effects of hypoxia on KDR expression provides a new explanation for the attenuation of VEGF-mediated angiogenic responses in hypoxic endothelial cells.
